So many women describe the same bewildering experience: they haven't changed their exercise routine, they're not doing anything new, and suddenly a tendon that was completely fine is sidelined for months. The frustrating part is that most are never told estrogen had anything to do with it. Knowing the mechanism doesn't fix the tendon overnight, but it does mean women can stop blaming themselves — and start asking the right questions.
Learn more about Rose →Tendon fibroblasts (tenocytes) express both estrogen receptor alpha and beta, meaning tendon tissue is directly responsive to circulating estrogen levels. When estrogen declines, these receptors receive less signaling, and the downstream effects on collagen synthesis and remodeling become measurable. This is not a metaphor — it is a documented receptor-level mechanism that explains why perimenopause and tendon problems so often arrive together.
Estrogen plays a direct role in upregulating type I collagen production, which is the primary structural protein in tendons. As estrogen falls, tenocytes produce less new collagen, meaning the tissue that takes daily mechanical load is being replenished more slowly than it is broken down. Over time, this net deficit in collagen turnover reduces the tendon's load-bearing capacity even before any acute injury occurs.
Research using ultrasound elastography has shown that tendon stiffness decreases in postmenopausal women compared to premenopausal women of similar activity levels, and that this difference is partially reversible with hormone therapy. A less stiff tendon absorbs force less efficiently, placing greater strain on the tissue during impact and loading activities like running, jumping, or even brisk walking. This mechanical change helps explain why injuries occur at exercise intensities that previously felt routine.
Estrogen has well-characterized anti-inflammatory properties, including modulation of inflammatory cytokines like IL-1 and TNF-alpha that are active in tendon tissue. When estrogen declines, the local inflammatory environment within tendons can become less well-regulated, meaning minor repetitive microtrauma triggers a more prolonged and dysregulated inflammatory response. This is one physiological reason why tendon injuries in perimenopause tend to linger rather than resolve on the expected timeline.
Tenocytes — the cells responsible for maintaining and repairing tendon structure — rely on estrogen signaling to remain metabolically active. Studies on tendon cell cultures show that estrogen deprivation reduces tenocyte proliferation and their ability to produce extracellular matrix proteins needed for repair. In practical terms, this means that when a perimenopausal woman's tendon sustains microtrauma, the cellular repair machinery is running at reduced capacity.
Much of the body's connective tissue repair — including tendon collagen remodeling — occurs during deep sleep, when growth hormone is released in significant pulses. Perimenopause is notorious for disrupting sleep through night sweats, frequent waking, and reduced slow-wave sleep duration. Women already dealing with compromised estrogen-dependent tendon biology are simultaneously losing the sleep-dependent repair window that healthy tendons depend on.
Estrogen supports muscle protein synthesis and muscle fiber maintenance, so declining levels during perimenopause contribute to gradual loss of muscle strength and mass — a process accelerated compared to age-matched men. When surrounding muscles are weaker, tendons absorb a disproportionate share of mechanical load during movement, exposing already compromised tissue to forces it is less equipped to handle. This muscle-tendon interaction is a compounding factor that is rarely discussed in injury consultations.
Perimenopause is not a smooth linear decline — it involves irregular hormonal fluctuations, and some evidence suggests that periods of relatively elevated or fluctuating reproductive hormones can transiently affect connective tissue laxity. Increased joint laxity changes the mechanical environment in which tendons operate, potentially increasing the risk of strain at the tendon-bone junction. Women may notice their vulnerability to injury varies from week to week, which can be partly explained by these hormonal oscillations.
Several studies — including imaging studies measuring tendon cross-sectional area and mechanical properties — have found that women using estrogen-containing hormone therapy have better tendon structure and stiffness profiles than untreated postmenopausal women. This is considered indirect but meaningful evidence that estrogen loss is causally involved in tendon deterioration, not merely coincidental. For women considering hormone therapy, tendon and musculoskeletal health is a legitimate part of the evidence-based conversation worth raising with a clinician.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.